SPDR S&P Biotech ETF
Real-time prices from Yahoo Finance's public feed. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Latest news
All XBI news ›SPDR S&P Biotech ETF $XBI Stock Sold by Balefire LLC
Balefire LLC cut its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 35.0% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 14,216…
SPDR S&P Biotech ETF $XBI Stock Purchased by Valeo Financial Advisors LLC
Valeo Financial Advisors LLC grew its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 159.8% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 19,221 shares of the exchange traded fund’s stock…
SPDR S&P Biotech ETF $XBI Stock Acquired by Ayalon Insurance Comp Ltd.
Ayalon Insurance Comp Ltd. grew its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 71.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission…
Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma
The VanEck Biotech ETF and State Street SPDR S&P Pharmaceuticals ETF both carry an identical expense ratio of 0.35%. The State Street SPDR S&P Pharmaceuticals ETF is more diversified with 62 holdings, while the VanEck Biotech ETF focuses…
Stocktwits Biotech Dealmaker — Viatris And GE Healthcare Buy What They Can Sell; Biohaven And Alector Sell Rights
Viatris agreed on Thursday to buy Pacira BioSciences for $1.65 billion in cash, or $36.50 a share. GE HealthCare agreed to pay $945 million in cash for Sofie Biosciences, a private U.S. firm that makes radioactive tracers for PET scans.…
Better Biotechnology ETF: First Trust FBT vs. VanEck BBH
The First Trust NYSE Arca Biotechnology Index Fund (FBT +2.00%) offers broader exposure and higher recent returns, while the VanEck Biotech ETF (BBH +2.75%) provides a lower-cost, highly concentrated portfolio of industry giants.…
Better Pharma ETF: iShares IHE vs. State Street XPH
The iShares U.S. Pharmaceuticals ETF (IHE +1.24%) offers a concentrated, market cap-weighted approach to drugmakers, while the State Street SPDR S&P Pharmaceuticals ETF (XPH +1.60%) provides broader, more equal-weighted exposure to the…
XBI Oct 2026 157.500 put (XBI261023P00157500)
stock price, news, quote and history Yahoo Finance UK XBI Oct 2026 157.500 put (XBI261023P00157500) - LLOY.L Lloyds Banking Group plc 101.60 +1.00 (+0.99%) - LIT.L Litigation Capital Management Limited 0.3950 +0.0750 (+23.44%) - LFT.AQ…
Up and down the ladder: The latest comings and goings
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for more than three decades. His stories explore prescription drug pricing, affordability and access, as well issues surrounding…
Trump, Earnings Drive Top-Rated Biotech Higher
Biotechs have been rallying since last week's U.S. election, as worries about potential drug pricing scrutiny under a Hillary Clinton presidency fade. Investors.com will undergo scheduled maintenance from 10:00 PM ET to 2:00 AM ET and some…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
themarketsdaily.com6
-
tradingview.com6
-
finance.yahoo.com5
-
fool.com5
-
investors.com4
Measured across the 4GenX news index. Headline tone is a simple word-based reading of the latest 61 headlines, not a forecast.